So far, 6 patients have been enrolled in the trial: 4 at the University Medical Center Hamburg-Eppendorf and 2 at Vivantes Klinikum Neukölln!
We are very much looking forward to further patients. Currently, six sites in Germany are activated, and many more will follow in the coming weeks. The other countries are also in the final stages of preparing the trial and will begin in the coming months.
